What is Verix?
Founded in 2004 and headquartered in Santa Clara, California, Verix specializes in delivering sophisticated business intelligence software. The company occupies a critical niche by providing AI-driven analytic solutions tailored specifically for the complex requirements of the Pharma and Consumer Packaged Goods (CPG) sectors. By transforming raw data into actionable insights, Verix enables sales and marketing departments to optimize their performance and streamline operational workflows. Its market position is defined by a deep understanding of industry-specific challenges, allowing the firm to offer highly specialized tools that drive revenue growth and market penetration for its enterprise clientele.
How much funding has Verix raised?
Verix has raised a total of $20.8M across 3 funding rounds:
Series B
$12.7M
Series A
$8M
Debt
$137K
Series B (2006): $12.7M with participation from Gemini Israel Ventures, Viola Group, and Hillsven Capital
Series A (2019): $8M, investors not publicly disclosed
Debt (2021): $137K supported by PPP
Key Investors in Verix
Gemini Israel Ventures
Gemini Investors is a private investment firm focused on the smaller end of the middle market, investing in established companies with experienced management teams and strong growth potential.
Viola Group
Viola Group is Israel's leading technology investment group, managing over $6 billion in assets and supporting entrepreneurs in building transformational technology companies.
Hillsven Capital
Hillsven Capital is an investment firm that provides strategic backing to technology-driven enterprises, focusing on long-term growth and market scalability.
What's next for Verix?
Looking ahead, the strategic deployment of the $137K capital is expected to accelerate Verix's product roadmap and expand its footprint in the global analytics market. As the demand for predictive intelligence continues to rise, the company is well-positioned to enhance its machine learning capabilities, potentially integrating more advanced automation features to support complex enterprise environments. The focus will likely remain on deepening its penetration within the pharmaceutical and CPG verticals while exploring adjacent markets where high-volume data analysis is paramount. By maintaining a disciplined approach to growth and innovation, Verix is poised to sustain its trajectory as a leader in the business intelligence landscape, ensuring long-term value creation for its stakeholders and partners.
See full Verix company page
